119 related articles for article (PubMed ID: 1884902)
21. Kidney biopsy findings in cyclosporine-treated patients with insulin-dependent diabetes mellitus.
Mihatsch MJ; Helmchen U; Casanova P; Habib R; Larsen S; Magil A; Noel LH; Rapola J; Ulrich J; Wallace AC
Klin Wochenschr; 1991 May; 69(8):354-9. PubMed ID: 1909398
[TBL] [Abstract][Full Text] [Related]
22. Induction and pathophysiology of remission of insulin-dependent diabetes mellitus during administration of ciclosporin. London Diabetes Study Group.
Dupre J; Hramiak I; Mahon JL; Stiller CR
Horm Res; 1990; 33(2-4):152-8. PubMed ID: 2210620
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporin A in insulin-dependent diabetes mellitus of recent onset: a pilot study in children.
Lévy-Marchal C; Czernichow P
Horm Res; 1988; 29(5-6):177-84. PubMed ID: 3065205
[TBL] [Abstract][Full Text] [Related]
24. A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy.
Vialettes B; Picq R; du Rostu M; Charbonnel B; Rodier M; Mirouze J; Vexiau P; Passa P; Pehuet M; Elgrably F
Diabet Med; 1990; 7(8):731-5. PubMed ID: 2147636
[TBL] [Abstract][Full Text] [Related]
25. Intravenous glucose tolerance and pancreatic islet beta-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporin.
Robertson RP; Franklin G; Nelson L
Diabetes; 1989 Jan; 38(1):58-64. PubMed ID: 2642435
[TBL] [Abstract][Full Text] [Related]
26. Nephrotoxicity of cyclosporin A in patients with newly diagnosed type 1 diabetes mellitus.
Feldt-Rasmussen B; Jensen T; Dieperink H; Mandrup-Poulsen T; Nerup J; Bendtzen K; Andersen V; Kemp E; Leyssac PP
Diabet Med; 1990 Jun; 7(5):429-33. PubMed ID: 2142040
[TBL] [Abstract][Full Text] [Related]
27. Effect of cyclosporin A on B-cell loss in type 1 (insulin-dependent) diabetes mellitus.
Vague P; Vialettes B; Picq R; Dol S; Lassmann-Vague V
Diabetologia; 1989 Dec; 32(12):887. PubMed ID: 2693167
[No Abstract] [Full Text] [Related]
28. Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up study.
Müller C; Zielinski CC; Kalinowski W; Wolf H; Mannhalter JW; Aschauer-Treiber G; Klösch-Kasparek D; Gaube S; Eibl MM; Schernthaner G
J Endocrinol; 1989 Apr; 121(1):177-83. PubMed ID: 2654321
[TBL] [Abstract][Full Text] [Related]
29. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
Mandrup-Poulsen T; Nerup J; Stiller CR; Marner B; Bille G; Heinrichs D; Martell R; Dupre J; Keown PA; Jenner MR
Lancet; 1985 Mar; 1(8429):599-602. PubMed ID: 2857945
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin A in treatment of new-onset type I diabetes mellitus.
O'Brien D; Butler N; Chase HP; Hammon R; Hayward A; Klingensmith G; Pontesilli O
Diabetes Care; 1988 Mar; 11(3):297. PubMed ID: 3046855
[No Abstract] [Full Text] [Related]
31. [Hypertension induced by cyclosporin A in insulin-dependent diabetic patients. A one-year follow-up].
Hannedouche T; Natov S; Garev L; Marques LP; Boitard C; Lacour B; Assan R; Bach JF; Grünfeld JP
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1347-50. PubMed ID: 2124478
[TBL] [Abstract][Full Text] [Related]
32. Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months.
Dupré J; Stiller CR; Gent M; Donner A; von Graffenreid B; Murphy G; Heinrichs D; Jenner MR; Keown PA; Laupacis A
Transplant Proc; 1988 Jun; 20(3 Suppl 4):184-92. PubMed ID: 3289204
[No Abstract] [Full Text] [Related]
33. Long-term effects of cyclosporin A on cultured mouse pancreatic islets.
Andersson A; Borg H; Hallberg A; Hellerström C; Sandler S; Schnell A
Diabetologia; 1984 Jul; 27 Suppl():66-9. PubMed ID: 6383922
[TBL] [Abstract][Full Text] [Related]
34. Diabetes, cyclosporin nephrotoxicity, and serum creatinine concentration.
McNally PG; Feehally J; Walls J
Diabet Med; 1991 Apr; 8(3):289. PubMed ID: 1828751
[No Abstract] [Full Text] [Related]
35. Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group.
Jenner M; Bradish G; Stiller C; Atkison P
Diabetologia; 1992 Sep; 35(9):884-8. PubMed ID: 1397785
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of insulin release in vitro mediated by mononuclear cells from diabetic patients treated with cyclosporin A or placebo.
Debray-Sachs M; Sai P; Feutren G; Lang F; Maugendre D; Boitard C; Hors J; Bach JF
Diabetes; 1988 Jul; 37(7):873-7. PubMed ID: 3290005
[TBL] [Abstract][Full Text] [Related]
37. No cyclosporin A to diabetic children.
Kitagawa T; Ludvigsson J
Diabetes Care; 1988 May; 11(5):447. PubMed ID: 3292172
[No Abstract] [Full Text] [Related]
38. Glucose homeostasis and insulin secretion during chronic treatment with cyclosporin in nondiabetic humans.
Robertson RP; Franklin G; Nelson L
Diabetes; 1989 Jan; 38 Suppl 1():99-100. PubMed ID: 2642866
[TBL] [Abstract][Full Text] [Related]
39. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
Keymeulen B; Vandemeulebroucke E; Ziegler AG; Mathieu C; Kaufman L; Hale G; Gorus F; Goldman M; Walter M; Candon S; Schandene L; Crenier L; De Block C; Seigneurin JM; De Pauw P; Pierard D; Weets I; Rebello P; Bird P; Berrie E; Frewin M; Waldmann H; Bach JF; Pipeleers D; Chatenoud L
N Engl J Med; 2005 Jun; 352(25):2598-608. PubMed ID: 15972866
[TBL] [Abstract][Full Text] [Related]
40. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.
Tugwell P; Bombardier C; Gent M; Bennett KJ; Bensen WG; Carette S; Chalmers A; Esdaile JM; Klinkhoff AV; Kraag GR
Lancet; 1990 May; 335(8697):1051-5. PubMed ID: 1970370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
